Pharmacogenomic and in silico identification of isoform-selective AKT inhibitors from Pithecellobium dulce for precision cancer therapy
Gnanaprakash Jeyaraj(Saveetha University), Weimim Xie(Hengyang Normal University), Kuppusamy Sathishkumar(Thiruvalluvar University), Santosh Chokkakula(Chungbuk National University), Bader Almutairi(King Saud University), Bing Yang(Krirk University)
Cited by 4
Related Papers
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
|Antiviral Research|2022|82
Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy
|Microorganisms|2023|77
Biosurfactant and enzyme mediated crude oil degradation by Pseudomonas stutzeri NA3 and Acinetobacter baumannii MN3
|3 Biotech|2017|63
SARS-CoV-2 drug resistance and therapeutic approaches
|Heliyon|2025|44